Insider · CIK 0001202285

HAYDEN DONALD J JR

Reports to the SEC for 6 companies · MONMOUTH JUNCTION, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001202285

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-02-14	Theseus Pharmaceuticals, Inc.U Disposition from Tender	Director	UDisposition from Tender	−10K sh	—	—	0
2024-02-14	Theseus Pharmaceuticals, Inc.Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−3,250 sh	—	—	0
2023-06-13	Theseus Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+19.5K sh	—	—	19,500
2023-06-13	Theseus Pharmaceuticals, Inc.Restricted Stock UnitA Award	Director	AAward	+3,250 sh	—	—	3,250
2022-12-30	Theseus Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+9,900 sh	$5.00	+$49.5K	10,000
2022-12-29	Theseus Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+100 sh	$5.00	+$500	100
2022-05-17	Theseus Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+60K sh	—	—	60,000
2020-05-29	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2020-02-10	RGNXREGENXBIO Inc.M Exercise/Conversion	Director	MExercise/Conversion	+24.8K sh	$0.85	+$21.1K	24,800
2020-02-10	RGNXREGENXBIO Inc.S Sale	Director	SSale	−24.8K sh	$50.11	−$1.24M	0
2020-02-10	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−24.8K sh	—	—	129,100
2020-02-05	RGNXREGENXBIO Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,000 sh	$0.85	+$1,700	2,000
2020-02-05	RGNXREGENXBIO Inc.S Sale	Director	SSale	−2,000 sh	$50.00	−$100K	0
2020-02-05	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,000 sh	—	—	153,900
2020-01-17	RGNXREGENXBIO Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,200 sh	$0.85	+$2,720	3,200
2020-01-17	RGNXREGENXBIO Inc.S Sale	Director	SSale	−3,200 sh	$50.01	−$160K	0
2020-01-17	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,200 sh	—	—	155,900
2020-01-14	RGNXREGENXBIO Inc.M Exercise/Conversion	Director	MExercise/Conversion	+30K sh	$0.85	+$25.5K	30,000
2020-01-14	RGNXREGENXBIO Inc.S Sale	Director	SSale	−30K sh	$45.60	−$1.37M	0
2020-01-14	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−30K sh	—	—	159,100
2019-05-31	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2019-04-09	INSMINSMED IncM Exercise/Conversion	Director	MExercise/Conversion	+6,286 sh	$3.03	+$19K	68,483
2019-04-09	INSMINSMED IncS Sale	Director	SSale	−6,286 sh	$32.99	−$207K	62,197
2019-04-09	INSMINSMED Inc · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−6,286 sh	—	—	3,714
2019-02-22	INSMINSMED IncM Exercise/Conversion	Director	MExercise/Conversion	+14.9K sh	$3.03	+$45.1K	77,097
2019-02-22	INSMINSMED IncS Sale	Director	SSale	−14.9K sh	$28.08	−$418K	62,197
2019-02-22	INSMINSMED Inc · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−14.9K sh	—	—	10,100
2019-02-15	INSMINSMED IncM Exercise/Conversion	Director	MExercise/Conversion	+100 sh	$3.03	+$303	62,297
2019-02-15	INSMINSMED IncS Sale	Director	SSale	−100 sh	$27.90	−$2,790	62,197
2019-02-15	INSMINSMED Inc · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−100 sh	—	—	24,900
2018-06-07	AMICUS THERAPEUTICS, INC.A Award	Director	AAward	+3,081 sh	—	—	8,895
2018-06-07	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)A Award	Director	AAward	+8,912 sh	—	—	8,912
2018-06-05	RGNXREGENXBIO Inc.M Exercise/Conversion	Director	MExercise/Conversion	+14.9K sh	$0.85	+$12.7K	14,900
2018-06-05	RGNXREGENXBIO Inc.S Sale	Director	SSale	−14.9K sh	$55.01	−$820K	0
2018-06-05	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−14.9K sh	—	—	189,100
2018-06-01	RGNXREGENXBIO Inc.M Exercise/Conversion	Director	MExercise/Conversion	+100 sh	$0.85	+$85	100
2018-06-01	RGNXREGENXBIO Inc.S Sale	Director	SSale	−100 sh	$55.00	−$5,500	0
2018-06-01	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−100 sh	—	—	204,000
2018-05-25	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2018-05-15	RGNXREGENXBIO Inc.M Exercise/Conversion	Director	MExercise/Conversion	+9,847 sh	$0.85	+$8,369.95	9,847
2018-05-15	RGNXREGENXBIO Inc.S Sale	Director	SSale	−9,847 sh	$50.06	−$493K	0
2018-05-15	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−9,847 sh	—	—	204,100
2018-05-15	INSMINSMED IncA Award	Director	AAward	+6,066 sh	—	—	62,197
2018-05-14	RGNXREGENXBIO Inc.M Exercise/Conversion	Director	MExercise/Conversion	+5,153 sh	$0.85	+$4,380.05	5,153
2018-05-14	RGNXREGENXBIO Inc.S Sale	Director	SSale	−5,153 sh	$50.04	−$258K	0
2018-05-14	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,153 sh	—	—	213,947
2018-05-09	RGNXREGENXBIO Inc.M Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$0.85	+$12.8K	15,000
2018-05-09	RGNXREGENXBIO Inc.S Sale	Director	SSale	−15K sh	$45.00	−$675K	0
2018-05-09	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	219,100
2018-01-02	AMICUS THERAPEUTICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$15.00	+$300K	25,814

Recent filings

Accepted (ET)
Feb 144
HAYDEN DONALD J JR0001104659-24-023563
SEC(opens sec.gov)
Jun 134
HAYDEN DONALD J JR0001745020-23-000037
SEC(opens sec.gov)
Jan 34
HAYDEN DONALD J JR0001104659-23-000080
SEC(opens sec.gov)
May 184
HAYDEN DONALD J JR0000899243-22-018615
SEC(opens sec.gov)
Jun 24
HAYDEN DONALD J JR0001562180-20-004066
SEC(opens sec.gov)
Feb 124
HAYDEN DONALD J JR0001562180-20-001108
SEC(opens sec.gov)
Feb 74
HAYDEN DONALD J JR0001562180-20-001013
SEC(opens sec.gov)
Jan 214
HAYDEN DONALD J JR0001562180-20-000452
SEC(opens sec.gov)
Jan 164
HAYDEN DONALD J JR0001562180-20-000391
SEC(opens sec.gov)

Companies

Address

11 DEER PARK DRIVE, SUITE 117

MONMOUTH JUNCTION, NJ, 08852